Sections
Shows
Events
Cipla seeks favourable policy for domestic pharma companies, urges govt to increase fund allocation for health sector
Sun Pharma Q3 net profit zooms nearly four-fold to Rs 1,242 crore; firm's shares rise 2% on BSE
GlaxoSmithKline bribed doctors, illegally boosted drug prices: China
Dilip Shanghvi: A look at the man behind the mega Sun Pharma-Ranbaxy deal
